The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of ranolazine in the prevention of
recurrent atrial fibrillation in post-cardioversion patients with heart failure and preserved
ejection fraction.